Key result
GIGYF1 represses cellular mRNA translation by binding to eIF3 and disrupting its interaction with eIF4G1, and its depletion induces a robust immune response by derepressing Ifnb1 mRNA translation.
GIGYF1 represses cellular mRNA translation, including the antiviral cytokine IFN-β, by sequestering eIF3 and preventing its binding to eIF4G1, which has implications for host-pathogen interactions.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for GIGYF1 in antiviral immunity; leaves open translational relevance in humans.
Summary Viruses commonly interfere with the function of the eukaryotic translation initiation factor 4G1 (eIF4G1), a pivotal factor in the recruitment of the eIF3 complex and ribosome to the mRNA. This results in the inhibition of general host protein synthesis and redirecting ribosomes toward viral mRNAs. Certain viruses also selectively repress the translation of mRNAs involved in the host antiviral response. GIGYF2 and its interacting cap-binding protein 4EHP enable the transcript-specific repression of mRNA translation mediated by microRNAs and RNA-binding proteins (RBPs). RNA viruses, such as SARS-CoV-2, exploit the GIGYF2/4EHP complex to selectively repress the translation of transcripts such as Ifnb1 mRNA, which encodes the antiviral cytokine Interferon β (IFN-β). Herein, we reveal that GIGYF1, a paralogue of GIGYF2, robustly represses cellular mRNA translation through a distinct mechanism independent of 4EHP. Upon recruitment to a target mRNA by RBPs, the C-terminal region of GIGYF1 binds to subunits of eIF3 at the interaction interface of eIF3-eIF4G1. This disrupts binding of eIF3 to eIF4G1, resulting in mRNA-specific translational repression. This mechanism exerts profound influences on the host cell’s response to viral infection. Depletion of GIGYF1 induces a robust immune response by derepressing Ifnb1 mRNA translation. Overall, our study highlights a unique mechanism of translational regulation by GIGYF1 that involves sequestering eIF3 and abrogating its binding to eIF4G1. This mechanism can be utilized by RBPs that interact with GIGYF1 to specifically repress the translation of their target mRNAs, significantly affecting critical biological processes, including host-pathogen interactions.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2023) studied Viral infection. GIGYF1 was evaluated on mRNA translation repression mechanism. GIGYF1 represses cellular mRNA translation by binding to eIF3 and disrupting its interaction with eIF4G1, and its depletion induces a robust immune response by derepressing Ifnb1 mRNA translation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: